Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGcp Asset Bckd Regulatory News (GABI)

Share Price Information for Gcp Asset Bckd (GABI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 68.20
Bid: 68.20
Ask: 69.40
Change: 0.00 (0.00%)
Spread: 1.20 (1.76%)
Open: 68.00
High: 68.20
Low: 68.00
Prev. Close: 68.20
GABI Live PriceLast checked at -
GCP Asset Backed Income is an Investment Trust

To generate attractive risk-adjusted returns through growing distributions and modest capital appreciation over the long term by investing in predominantly UK loans.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Revolving Credit Facility

21 Aug 2018 10:04

RNS Number : 4233Y
GCP Asset Backed Income Fund Ltd
21 August 2018
 

 

GCP Asset Backed Income Fund Limited

(the "Company" and/or "GCP Asset Backed")

LEI 213800FBBZCQMP73A815

Revolving Credit Facility

21 August 2018

GCP Asset Backed, which invests in asset backed loans, today announces that it has entered into an agreement with Royal Bank of Scotland International Limited in respect of an increase to the £15 million revolving credit facility entered into on 13 January 2017. The increased facility is for an amount of £30 million and for a term of two years (plus 12 month extension option, with lender approval), of which £14 million has been drawn, as at the date of this announcement.

As announced on 26 July 2018, net proceeds of any C share issue in October 2018 may be used to repay any monies drawn down by the Company under this revolving credit facility which have been used to fund the whole or part of new investments in the period from 14 July 2018 to raising of the C share proceeds.

Interest on amounts drawn under the facility is charged at a rate of LIBOR plus a margin. The margin on the facility has been reduced from 2.75% to 2.10%.

For further information, please contact:

Gravis Capital Management Limited +44 (0) 20 3405 8500

David Conlon

david.conlon@graviscapital.com

Dion Di Miceli

dion.dimiceli@graviscapital.com

Cenkos Securities plc

+44 (0)20 7397 8900

Tom Scrivens

tscrivens@cenkos.com

Oliver Packard

opackard@cenkos.com

Sapna Shah

sshah@cenkos.com

Notes to Editors

The Company

The Company is a closed ended investment company traded on the Main Market of the London Stock Exchange. Its investment objective is to generate attractive risk-adjusted returns primarily through regular, growing distributions and modest capital appreciation over the long term.

The Company seeks to meet its investment objective by making investments in a diversified portfolio of predominantly UK based asset backed loans which have contracted, predictable medium to long term cash flows and/or physical assets.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCGMGZRLMZGRZG
Date   Source Headline
26th Jul 20224:06 pmRNSHolding(s) in Company
22nd Jul 20227:00 amRNSDividend Declaration
19th Jul 20227:00 amRNSNet Asset Value and Investment Update
17th May 20224:52 pmRNSResults of Annual General Meeting
29th Apr 20227:00 amRNSDividend Declaration
29th Apr 20227:00 amRNSInvestor Report at 31 March 2022
20th Apr 20227:00 amRNSNet Asset Value and Investment Update
6th Apr 20227:00 amRNSNotice of Annual General Meeting
24th Mar 20227:00 amRNSAnnual Report & Financial Statements
25th Feb 20227:00 amRNSCo-living Group Loan Update
3rd Feb 20227:00 amRNSCo-living Group Loan Update
31st Jan 20227:00 amRNSInvestor Report at 31 December 2021
27th Jan 20227:00 amRNSDividend Declaration
25th Jan 20227:00 amRNSNet Asset Value and Investment Update
22nd Dec 20219:03 amRNSCo-Living 2021 Year End Update
3rd Nov 20217:00 amRNSDividend Declaration
29th Oct 20217:00 amRNSInvestor Report at 30 September 2021
15th Oct 20217:00 amRNSNet Asset Value and Investment Update
28th Sep 20217:00 amRNSHalf-year Report
16th Sep 20217:00 amRNSCo-living Group Loan Update
13th Sep 20217:00 amRNSCo-living Group Loan Update and Net Asset Value
20th Aug 20217:00 amRNSExtension to term of Revolving Credit Facility
30th Jul 20217:00 amRNSInvestor Report at 30 June 2021
22nd Jul 20217:00 amRNSDividend Declaration
15th Jul 20217:00 amRNSNet Asset Value and Investment Update
17th May 20212:13 pmRNSResults of Annual General Meeting
4th May 20217:00 amRNSInvestor Report at 31 March 2021
29th Apr 20215:42 pmRNSDirector/PDMR Shareholding
29th Apr 20217:00 amRNSDividend Declaration
20th Apr 20217:00 amRNSNet Asset Value and Investment Update
16th Apr 20217:00 amRNSNotice of Annual General Meeting
31st Mar 20217:00 amRNSTotal Voting Rights
23rd Mar 20217:00 amRNSAnnual Report & Financial Statements
18th Mar 20217:00 amRNSTransaction in Own Shares
15th Mar 20217:00 amRNSTransaction in Own Shares
12th Mar 20217:00 amRNSTransaction in Own Shares
10th Mar 20217:00 amRNSTransaction in Own Shares
8th Mar 20217:00 amRNSCompliance with Market Abuse Regulation
29th Jan 20217:00 amRNSInvestor Report at 31 December 2020
26th Jan 20217:00 amRNSDividend Declaration & Scrip Dividend Suspension
18th Jan 20217:00 amRNSNet Asset Value and Investment Update
4th Dec 20207:00 amRNSInvestment Manager change of control
30th Nov 20207:00 amRNSTotal Voting Rights
26th Nov 20207:00 amRNSSpecial Dividend Declaration
5th Nov 20207:00 amRNSTransaction in Own Shares
2nd Nov 20207:00 amRNSTransaction in Own Shares
2nd Nov 20207:00 amRNSInvestor Report at 30 September 2020
30th Oct 20207:00 amRNSTransaction in Own Shares
29th Oct 20207:00 amRNSTransaction in Own Shares
28th Oct 20207:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.